Biomaterials and Biofabrication Push Medical Implants Toward Multifunctional Devices

Medical implants are no longer passive pieces of hardware. A titanium screw or an artificial hip must do far more than provide mechanical support or stand in for damaged tissue: it has to interact appropriately with the surrounding biology, resist infection, promote tissue integration, and keep performing for years inside a hostile, load-bearing environment. A new collection of research published in Frontiers in Bioengineering and Biotechnology argues that meeting those demands requires something implants have rarely enjoyed before — a genuinely integrated design philosophy in which mechanics, materials, manufacturing, and biology are optimized together rather than one at a time.

The collection, a Research Topic titled Advances in Biomaterials and (Bio)fabrication for Medical Implants, was curated by an editorial team spanning ETH Zurich, the University of Wisconsin-Madison, and the Swiss Federal Laboratories for Materials Science and Technology, Empa. It brings together ten studies covering orthopedic, dental, cardiovascular, and veterinary applications. The materials and clinical indications differ widely from paper to paper, but the editors identify a shared objective running through all of them: improving the interaction between implant design, mechanical function, and the biological environment that ultimately decides whether a device succeeds or fails.

Mechanical reliability remains the non-negotiable foundation of implant design, and several contributions tackle it head-on. In veterinary orthopedics, Losey and Maritato characterized the screw retention and bending behavior of polyaxial combination-hole locking plates, generating mechanical data directly relevant to fracture fixation in animal patients. Meanwhile, Sim and colleagues approached implant mechanics from a computational angle, investigating the verification, validation, and uncertainty quantification of finite element models of pedicle screw assemblies — the constructs surgeons use to stabilize spinal segments. Their findings carry a sobering message for the medical-device industry: assumptions made at implant interfaces can substantially alter predicted mechanical behavior, which means computational models must be anchored by experimental validation before they can be trusted in device development.

Perhaps the most viral idea in the collection is that the surface of an established structural material can be reprogrammed to steer biology without touching the underlying implant architecture. Hertzberg-Boelch and colleagues investigated calcium hydroxide-coated titanium implants and reported increased bone-implant contact in vivo, along with potential antibacterial effects. Chen and colleagues explored nano-thin amorphous tantalum coatings on titanium implants for acetabular bone-defect reconstruction, combining preclinical evaluation with initial clinical observations. Both studies demonstrate that decades-old titanium hardware can gain new biological functions through surface engineering alone — a route that could accelerate translation because the bulk implant, its manufacturing chain, and its regulatory profile remain largely unchanged.

The implant-tissue interface is also where one of the most persistent complications of medical devices occurs: infection. Implant-associated biofilms — structured communities of bacteria encased in a protective matrix — are notoriously resistant to antibiotics and the immune system, and once established they are extremely difficult to eradicate. Liu and colleagues reviewed the mechanisms of bacterial biofilm resistance on orthopedic implants and surveyed current strategies for anti-biofilm coatings. Brümmer and colleagues, working with a multispecies peri-implantitis biofilm model, demonstrated the potential of locally applied antibiotics for reducing bacterial biofilms across different implant materials. Together, the two studies underscore both the importance of preventing biofilm formation in the first place and the promise of targeted local antimicrobial strategies for managing infections that have already taken hold.

Soft and composite biomaterials are introducing functions that conventional metallic implants simply cannot deliver. Meng and colleagues developed an injectable, in-situ curable hydrogel for hemostasis within the medullary cavity — the hollow core of long bones where uncontrolled bleeding can complicate surgery. The material combines injectability with rapid curing and mechanical stability, allowing it to be delivered as a liquid and then set in place exactly where it is needed. Rezvova and colleagues investigated carbon-nanotube-reinforced polyvinyl alcohol cryogels for cardiovascular applications, showing how nanoscale reinforcement can be used to tune the mechanical behavior of highly hydrated materials. The work illustrates a broader principle: nanoscale additives can give tissue-like, water-rich gels the strength and resilience that demanding physiological loading requires.

Biofabrication takes this control a step further, enabling simultaneous command over material architecture and biological function across multiple length scales. Chang and colleagues used coaxial electrospinning to produce poly(ε-caprolactone)/gelatin core-shell scaffolds for localized delivery of metronidazole and dexamethasone, packing antibiofilm and anti-inflammatory functions into a single fibrous construct. The core-shell geometry is the key trick: one material forms the structural core while another forms the drug-bearing shell, allowing two therapeutic payloads to be released on different timescales from one scaffold. Sallustio and colleagues developed a load-bearing vascular graft that combines an elastin-like recombinamer hydrogel with a silk fibroin textile structure, demonstrating how different biomaterial classes can be integrated to reproduce the demanding mechanical and biological functions of native blood vessels.

Taken together, the editors argue, these studies point to the single most important direction in implant research: mechanics, materials, manufacturing, and biology cannot be optimized independently. An implant may possess excellent mechanical properties yet fail because of poor tissue integration or infection. Conversely, a highly bioactive material has limited clinical value if it cannot withstand physiological loading, be manufactured reproducibly, or be incorporated into a practical implant design. The lesson is as much about systems thinking as it is about any individual material or coating.

This is particularly relevant as implant development moves toward increasingly multifunctional systems. Surface coatings can modify the response of established metallic implants; hydrogels and composite materials can introduce tissue-like mechanical behavior or local therapeutic functions; advanced fabrication methods can control architecture across multiple length scales; and computational models can help evaluate designs before extensive experimental testing. The challenge, the editors conclude, is increasingly not whether each of these technologies can work individually, but how they can be integrated into robust and clinically translatable medical devices — a question that will define the next generation of implants.

The studies collected in the Research Topic provide examples of this integration across different implant applications and stages of development, from early-stage hydrogels to coatings already showing clinical observations. The editors emphasize that continued collaboration between materials scientists, engineers, biologists, clinicians, and manufacturers will be essential to translate these advances into implants that are not only mechanically reliable, but also better adapted to the biological environments in which they must function. As additive manufacturing, surface engineering, nanomaterials, and computational modeling continue to converge, the humble implant is quietly transforming into something far more ambitious: a device designed as much for the cells around it as for the loads it must carry.

Subject of Research: Advances in biomaterials and biofabrication for medical implants

Article Title: Editorial: Advances in biomaterials and (Bio)fabrication for medical implants

Article References: Du, X., Kuang, X., Blugan, G., & Ferguson, S. J. (2026). Editorial: Advances in biomaterials and (Bio)fabrication for medical implants. Frontiers in Bioengineering and Biotechnology, 14, Article 2015618. https://doi.org/10.3389/fbioe.2026.2015618

Image Credits: AI Generated

DOI: 10.3389/fbioe.2026.2015618

Keywords: Editorial, Advances, biomaterials, fabrication, medical, implants, scientific research